C126H152F6N32O10S — CID 160519708
[4-[[2-(1,3-benzothiazol-2-yloxy)-4-methylphenyl]methyl]piperazin-1-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;[4-[[2-(1-cyclopropylpiperidin-4-yl)oxy-4-methylphenyl]methyl]piperazin-1-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;[4-[[3-(1-cyclopropylpiperidin-4-yl)oxy-5-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;[4-[(4-methyl-2-pyrimidin-5-yloxyphenyl)methyl]piperazin-1-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;[3-(prop-1-en-2-ylamino)pyrazol-1-yl]-[4-[[3-pyrimidin-5-yloxy-5-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]methanone (PubChem CID 160519708) has the molecular formula C126H152F6N32O10S and a molecular weight of 2420.87 g/mol. Its IUPAC name is [4-[[2-(1,3-benzothiazol-2-yloxy)-4-methylphenyl]methyl]piperazin-1-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;[4-[[2-(1-cyclopropylpiperidin-4-yl)oxy-4-methylphenyl]methyl]piperazin-1-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;[4-[[3-(1-cyclopropylpiperidin-4-yl)oxy-5-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;[4-[(4-methyl-2-pyrimidin-5-yloxyphenyl)methyl]piperazin-1-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;[3-(prop-1-en-2-ylamino)pyrazol-1-yl]-[4-[[3-pyrimidin-5-yloxy-5-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]methanone.
| Compound Name | [4-[[2-(1,3-benzothiazol-2-yloxy)-4-methylphenyl]methyl]piperazin-1-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;[4-[[2-(1-cyclopropylpiperidin-4-yl)oxy-4-methylphenyl]methyl]piperazin-1-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;[4-[[3-(1-cyclopropylpiperidin-4-yl)oxy-5-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;[4-[(4-methyl-2-pyrimidin-5-yloxyphenyl)methyl]piperazin-1-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;[3-(prop-1-en-2-ylamino)pyrazol-1-yl]-[4-[[3-pyrimidin-5-yloxy-5-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]methanone |
|---|---|
| PubChem CID | 160519708 |
| Molecular Formula | C126H152F6N32O10S |
| Molecular Weight | 2420.87 g/mol |
| Exact Mass | 2419.20 |
| IUPAC Name | [4-[[2-(1,3-benzothiazol-2-yloxy)-4-methylphenyl]methyl]piperazin-1-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;[4-[[2-(1-cyclopropylpiperidin-4-yl)oxy-4-methylphenyl]methyl]piperazin-1-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;[4-[[3-(1-cyclopropylpiperidin-4-yl)oxy-5-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;[4-[(4-methyl-2-pyrimidin-5-yloxyphenyl)methyl]piperazin-1-yl]-[3-(prop-1-en-2-ylamino)pyrazol-1-yl]methanone;[3-(prop-1-en-2-ylamino)pyrazol-1-yl]-[4-[[3-pyrimidin-5-yloxy-5-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]methanone |
| SMILES | C=C(C)Nc1ccn(C(=O)N2CCN(Cc3cc(OC4CCN(C5CC5)CC4)cc(C(F)(F)F)c3)CC2)n1.C=C(C)Nc1ccn(C(=O)N2CCN(Cc3cc(Oc4cncnc4)cc(C(F)(F)F)c3)CC2)n1.C=C(C)Nc1ccn(C(=O)N2CCN(Cc3ccc(C)cc3OC3CCN(C4CC4)CC3)CC2)n1.C=C(C)Nc1ccn(C(=O)N2CCN(Cc3ccc(C)cc3Oc3cncnc3)CC2)n1.C=C(C)Nc1ccn(C(=O)N2CCN(Cc3ccc(C)cc3Oc3nc4ccccc4s3)CC2)n1 |
| InChI | InChI=1S/C27H35F3N6O2.C27H38N6O2.C26H28N6O2S.C23H24F3N7O2.C23H27N7O2/c1-19(2)31-25-7-10-36(32-25)26(37)35-13-11-33(12-14-35)18-20-15-21(27(28,29)30)17-24(16-20)38-23-5-8-34(9-6-23)22-3-4-22;1-20(2)28-26-10-13-33(29-26)27(34)32-16-14-30(15-17-32)19-22-5-4-21(3)18-25(22)35-24-8-11-31(12-9-24)23-6-7-23;1-18(2)27-24-10-11-32(29-24)26(33)31-14-12-30(13-15-31)17-20-9-8-19(3)16-22(20)34-25-28-21-6-4-5-7-23(21)35-25;1-16(2)29-21-3-4-33(30-21)22(34)32-7-5-31(6-8-32)14-17-9-18(23(24,25)26)11-19(10-17)35-20-12-27-15-28-13-20;1-17(2)26-22-6-7-30(27-22)23(31)29-10-8-28(9-11-29)15-19-5-4-18(3)12-21(19)32-20-13-24-16-25-14-20/h7,10,15-17,22-23H,1,3-6,8-9,11-14,18H2,2H3,(H,31,32);4-5,10,13,18,23-24H,1,6-9,11-12,14-17,19H2,2-3H3,(H,28,29);4-11,16H,1,12-15,17H2,2-3H3,(H,27,29);3-4,9-13,15H,1,5-8,14H2,2H3,(H,29,30);4-7,12-14,16H,1,8-11,15H2,2-3H3,(H,26,27) |
| InChIKey | QUCORRFTHRXBEF-UHFFFAOYSA-N |
| XLogP | 21.61 |
| TPSA | 384.08 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 38 |
| Rotatable Bonds | 32 |
| Heavy Atoms | 175 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2420.87 |
| LogP ≤ 5 | 21.61 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 38 |